Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance
- 256 Downloads
We previously demonstrated that the detection of circulating cancer cells (CCC) expressing survivin mRNA could provide valuable information for predicting recurrence in patients with breast, lung, gastric and colorectal carcinoma. The purpose of this study is to investigate whether the detection of survivin-expressing CCC in the peripheral blood is also useful for predicting recurrence in patients with esophageal squamous cell carcinoma (ESCC). Blood samples obtained from 108 ESCC patients and 75 healthy volunteers were quantitatively investigated by a technique that detected reverse transcription-polymerase chain reaction products based on a hybridization-enzyme linked immunosorbent essay. Not all of the patients were available for the follow-up study. Only 48 patients who were treated with similar adjuvant therapy regimens were available and followed-up for 33 months after the initial assay test. Survivin-expressing CCC were detected in 51 (47.2%) patients. The presence of survivin-expressing CCC was found to be significantly associated with depth of invasion, vascular invasion, nodal status, and disease stages (P = 0.032, 0.019, 0.018, and 0.001, respectively). During the follow-up period, patients who had positive survivin expressions had a higher relapse rate and a shorter survival time than those who had negative survivin expressions (P = 0.002 and 0.016, respectively). Examination of survivin-expressing CCC could provide valuable information in the prediction of haematogenous recurrence as well as in the prognosis of ESCC.
KeywordsSurvivin Circulating cancer cells ESCC RT-PCR ELISA
This study was partially supported by grants from the Chengdu Municipal Department of Science and Technology (Grant No. 07GGYB240SF-143), and the Sichuan Provincial Department of Science and Technology (Grant No. 07JY029-091).
- 2.Roder JD, Stein HJ, Siewert JR (1995) Oesophageal carcinoma. In: Hermaneck P, Gospodarowicz MK, Henson DE (eds) Prognostic factors in cancer, UICC. Springer-Verlag, Berlin, p 37Google Scholar
- 11.Chiou SK, Jones MK, Tarnawski AS (2003) Survivin–an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 9:125–129Google Scholar
- 19.Watanable H, Jass JR, Sobin LH (eds) (1990) Histological typing of esophageal and gastric tumors. Springer-Verlag, BerlinGoogle Scholar
- 20.Sobin H, Wittekind C (eds) (2002) UICC: TNM classification of malignant tumors, 6th edn. Wiley, New YorkGoogle Scholar
- 22.Mino-Miyagawa N, Kimura Y, Hamamoto K (1990) Tumor-antigen 4: its immunohistochemical distribution and tissue and serum concentrations in squamous cell carcinoma of the lung and esophagus. Cancer 66:1505–1512. doi: 10.1002/1097-0142(19901001)66:7<1505::AID-CNCR2820660712>3.0.CO;2-V CrossRefPubMedGoogle Scholar